Press Release

Children with prediabetes and obesity may be more likely to progress to diabetes

Washington, DC October 12, 2023

Metformin, lifestyle changes may prevent type 2 diabetes in children with prediabetes

A new Journal of the Endocrine Society study highlights how to identify children at high risk of developing type 2 diabetes and strategies for prevention, such as anti-obesity or anti-diabetes medication and lifestyle changes. Prediabetes is a health condition in which blood sugar levels are higher than normal, but not yet high enough to be diagnosed as type 2 diabetes. Prediabetes increases the risk of developing chronic kidney disease, heart disease and stroke. Around 5%-10% of adults with prediabetes develop diabetes each year.  Over the past three decades, there has been a sharp increase in the incidence and prevalence of childhood obesity, prediabetes and type 2 diabetes. At least 1 in 5 adolescents are estimated to have prediabetes. It is not clear whether the adult definition of prediabetes is appropriate for children as fewer progress to diabetes during childhood. “We found that higher levels on certain diabetes screening tests (non-fasting glucose and hemoglobin A1c) and worsening obesity may better predict diabetes risk in children,” said study author Ashley H. Shoemaker, M.D., M.S.C.I., of Vanderbilt University Medical Center in Nashville, Tenn. “This is a real-world study that highlights ways to identify the children at highest risk for diabetes and possible strategies for diabetes prevention in children such as treatment with anti-diabetes or anti-obesity medications. Our study found patients who were on metformin had lower blood sugar levels and were slower to progress to diabetes.” The researchers found 6.5% of 552 pediatric patients with prediabetes developed type 2 diabetes over the 7-year period of their study. They identified a few risk factors, including higher HbA1C and non-fasting glucose levels, and worsening obesity. The study found boys progressed more commonly and more quickly to type 2 diabetes than girls. “Weight stabilization and metformin therapy could be important interventions for diabetes prevention in children,” Shoemaker said. The other authors of this study are Natasha Belsky of Vanderbilt University School of Medicine in Nashville, Tenn.; and Jaclyn Tamaroff of Vanderbilt University Medical Center. The study was funded by the National Institute of Diabetes and Digestive and Kidney Diseases and the National Center for Advancing Translational Sciences. The manuscript, Risk Factors for Progression to Type 2 Diabetes in a Pediatric Prediabetes Clinic Population,” was published online.

About Endocrine Society

Endocrinologists are at the core of solving the most pressing health problems of our time, from diabetes and obesity to infertility, bone health, and hormone-related cancers. The Endocrine Society is the world’s oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.

The Society has more than 18,000 members, including scientists, physicians, educators, nurses, and students in 122 countries. To learn more about the Society and the field of endocrinology, visit our site at www.endocrine.org. Follow us on X (formerly Twitter) at @TheEndoSociety and @EndoMedia.

Media Contacts

Colleen Williams Senior Communications Manager, Public Relations Phone: (202)-971-3611 [email protected]

Jenni Glenn Gingery Director, Communications and Media Relations Phone: (202)-971-3655 [email protected]

All News & Advocacy

Hill Event
Podcast

Endocrine News Podcast

EndocrineNewsPodcast
The Endocrine News podcast brings you the latest research and clinical advances from experts in the field, whether you are in your car, office, or out for a run.

The Endocrine News podcast brings you the latest research and clinical advances from experts in the field, whether you are in your car, office, or out for a run.

Bench to Bedside

Endocrine Society Journals

Research
Our top-ranked peer-reviewed journals are among the first to publish major developments and discovery milestones.

Our top-ranked peer-reviewed journals are among the first to publish major developments and discovery milestones.

Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.